Archive

EASD 2021: Osteoporosis drug appears to lower diabetes risk

Written by | 5 Oct 2021

Treatment with alendronate, an osteoporosis drug, appears to reduce the risk of developing type 2 diabetes, researchers reported on Sept. 26, 2021 at the annual meeting of the […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.